Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
-д хадгалсан:
| Формат: | Цахим Сэтгүүл |
|---|---|
| Хэвлэсэн: |
Bernstein Institutional Services LLC
|
| Онлайн хандалт: | Available in Business Source Ultimate. Нээлттэй каталог буюу OPAC дээр харах |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Ижил төстэй зүйлс: Black Book - Multiple Myeloma: Patients, Penetration Price & Duration Offer Upside for Celgene Through 2015
- Celgene Corporation SWOT Analysis
- White Book - Celgene: An Abundance of Revlimid Opportunities in Myeloma, But Maintenance Is the Biggest Driver
- Black Book - Inco: Upsides from Cost Reductions, Commodity Price Rebounds, Volume Gains & Exploration
- Bernstein Black Book - Biosimilars: Quo Vadis - A Snapshot of the Biosimilar Industry Halfway Through Its Formation
- Clinical lymphoma & myeloma
- Clinical Lymphoma and Myeloma